1. Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)

   • Selma B. Souto
   • Eliana B. Souto
   • José L. Medina

   Review Article 06 April 2011 Pages: 653 - 661

2. Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study

   • Rosa M. Antonijoan
   • Ignasi Gich
   • Manel J. Barbanoj

   Clinical Trial 16 February 2011 Pages: 663 - 669

   

3. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation

   • Itziar Oteo
   • John C. Lukas
   • Rosario Calvo

   Clinical Trial 17 February 2011 Pages: 671 - 679

   

4. Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration

   • Hélène Théophile
   • Ghada Miremont-Salamé
   • Françoise Haramburu

   Special Article 20 May 2011 Pages: 681 - 686

   

5. Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate

   • Kesara Na-Bangchang
   • Ronnatrai Ruengweerayut
   • Walther H. Wernsdorfer

   Pharmacodynamics 10 May 2011 Pages: 687 - 691

6. Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer

   • Troels K. Bergmann
   • Henrik Gréen
   • Curt Peterson

   Pharmacogenetics 16 February 2011 Pages: 693 - 700

   

7. Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers

   • Jiake He
   • Zhixia Qiu
   • Xijing Chen

   Pharmacogenetics 17 February 2011 Pages: 701 - 707

   

8. Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers

   • Daniel Y. Ng
   • Sophie L. Stocker
   • Richard O. Day

   Pharmacokinetics and Disposition 23 December 2010 Pages: 709 - 713

   

9. Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol

   • Hanna Nylén
   • Sofia Sergel
   • Ulf Diczfalusy

   Pharmacokinetics and Disposition 19 January 2011 Pages: 715 - 722

   

10. The use of hypnosedative drugs in a university hospital: has anything changed in 10 years?

    • Annemie Somers
    • Hugo Robays
    • Mirko Petrovic

    Pharmacoepidemiology and Prescription 29 January 2011 Pages: 723 - 729

11. Psychotropic drug use in community-dwelling elderly people—characteristics of persistent and incident users

    • Maria Rikala
    • Maarit Jaana Korhonen
    • Sirpa Hartikainen

    Pharmacoepidemiology and Prescription 05 February 2011 Pages: 731 - 739

12. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits

    • Lina M. Hellström
    • Åsa Bondesson
    • Tommy Eriksson

    Pharmacoepidemiology and Prescription 12 February 2011 Pages: 741 - 752

    

13. Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis

    • Isabel Spriet
    • Wouter Meersseman
    • Ludo Willems

    Short Communication 03 June 2011 Pages: 753 - 755

14. Hyperkalaemia associated with hydroxyurea in a patient with polycythaemia vera

    • Srecko Marusic
    • Nives Gojo-Tomic
    • Velimir Bozikov

    Letter to the Editors 14 December 2010 Pages: 757 - 758